Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2013

Feb 19, 2013

30016_dirs_2013-02-19_cd402e12-80ee-487d-8143-dea66b183293.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-02-14

Reporting Person: Williams Michael J PhD (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-14 Common Stock M 258 Acquired 9424 Direct
2013-02-14 Common Stock M 258 Acquired 9682 Direct
2013-02-14 Common Stock M 399 Acquired 10081 Direct
2013-02-14 Common Stock M 400 Acquired 10481 Direct
2013-02-14 Common Stock M 343 Acquired 10824 Direct
2013-02-14 Common Stock F 835 $91.68 Disposed 9989 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-14 Non-Qualified Stock Option (right to buy) $91.68 A 13018 Acquired 2020-02-13 Common Stock (13018) Direct
2013-02-14 Incentive Stock Option (right to buy) $91.68 A 1090 Acquired 2020-02-13 Common Stock (1090) Direct
2013-02-14 Restricted Stock Unit $ A 1363 Acquired Common Stock (1363) Direct
2013-02-14 Restricted Stock Unit $ M 258 Disposed Common Stock (258) Direct
2013-02-14 Restricted Stock Unit $ M 258 Disposed Common Stock (258) Direct
2013-02-14 Restricted Stock Unit $ M 399 Disposed Common Stock (399) Direct
2013-02-14 Restricted Stock Unit $ M 400 Disposed Common Stock (400) Direct
2013-02-14 Restricted Stock Unit $ M 343 Disposed Common Stock (343) Direct

Footnotes

F1: Grant of options to buy shares of common stock becomes exercisable as to 2,822 shares on 02/14/2014, 02/14/2015 and 02/14/2016, 2,821 shares on 02/14/2017, and the remaining 1,731 shares on 02/14/2018.

F2: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2018) of the grant.

F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.